Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Choosing between index funds and mutual funds can significantly impact your investment returns. Understand the key factors to make informed decisions.
25,127 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
UBS raises AMD’s target to $670, a sharp upgrade that highlights strong AI-driven data center demand. Traders watch f...
A bold revenue target from Micron points to a surprisingly durable AI demand wave. This piece breaks down what the gu...
General Motors stock surged 65% in the last year, leaving investors wondering if the rally has legs. This article cut...
SpaceX embodies big dreams and bigger valuations. This piece digs into Morningstar's fair value for Spacex, why the m...
Singapore's financial regulator placed Hyperliquid on its Investor Alert List, marking a consumer-protection test for...
A near-10-year divorce can erase months of divorced-spouse Social Security benefits. The calendar, not sentiment, det...
Bloom Energy has sprinted higher this year on an AI-powered energy story. As a late entrant, you’ll want a clear view...
Seagate Technology has rallied about 250% year-to-date as AI storage demand accelerates. This update weighs whether t...
In a wave of filings, multiple lawsuits claim hometap mischaracterized its HEI agreements and breached TILA, intensif...
A wall street analyst just stirred a valuation debate around Palantir. This deep-dive breaks down what undervalued co...
Tesla's delivery report just signaled a demand rebound. In this analysis, we uncover three takeaways investors can us...